COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, Aug. 16, 2022 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
1 256 new cases, bringing the total number of people infected to 1,165,128*;
36 new deaths reported in the last 24 hours, for a total of 16,165 deaths;
4,109 health care workers absent for COVID-related reasons (preventive withdrawal, isolation, awaiting results, etc.);
1,964 hospitalizations, including 679 due to COVID-19, for a decrease of 29 compared to the previous day;
280 new entries,
309 new discharges;
50 people in intensive care, including 29 due to COVID-19, for a decrease of 5 compared to the previous day;
20 new entries,
25 new discharges;
9,362 samples conducted on August 14;
276,642 self-declared rapid tests so far, including 231,497 positive: 241 declared for yesterday, including 199 positive.
*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.
Vaccination
11,652 doses administered are added, for a cumulative total of 20,468,759 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...
Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...
A news report from CRI Online:
In August 2023, the United Nations General Assembly (UNGA) adopted the resolution "International Decade of Sciences for Sustainable Development 2024-2033" (Sciences Decade). This resolution offers a distinctive...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II between July 6, 2021 and November 8, 2022, both dates inclusive (the "Class...
Angara, the leading online DTC fine jewelry retail brand, has been honored with a Gold Stevie® Award for its "Celebrate with Color" campaign in the Marketing Campaign of the Year - Retail category in the 22nd Annual American Business...